These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 15937546)

  • 21. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K; Sheng H; Shao J; Beauchamp RD
    Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of TGF-beta related Smad proteins in human epithelial skin tumors.
    Lange D; Persson U; Wollina U; ten Dijke P; Castelli E; Heldin CH; Funa K
    Int J Oncol; 1999 Jun; 14(6):1049-56. PubMed ID: 10339656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I.
    Liu X
    Cell Motil Cytoskeleton; 2008 Dec; 65(12):935-44. PubMed ID: 18792103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression.
    Hoot KE; Lighthall J; Han G; Lu SL; Li A; Ju W; Kulesz-Martin M; Bottinger E; Wang XJ
    J Clin Invest; 2008 Aug; 118(8):2722-32. PubMed ID: 18618014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGF-β1 mediates epithelial to mesenchymal transition via the TGF-β/Smad pathway in squamous cell carcinoma of the head and neck.
    Yu C; Liu Y; Huang D; Dai Y; Cai G; Sun J; Xu T; Tian Y; Zhang X
    Oncol Rep; 2011 Jun; 25(6):1581-7. PubMed ID: 21479366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.
    Piccirillo CA; Letterio JJ; Thornton AM; McHugh RS; Mamura M; Mizuhara H; Shevach EM
    J Exp Med; 2002 Jul; 196(2):237-46. PubMed ID: 12119348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma.
    Bu F; Liu X; Li J; Chen S; Tong X; Ma C; Mao H; Pan F; Li X; Chen B; Xu L; Li E; Kou G; Han J; Guo S; Zhao J; Guo Y
    Oncotarget; 2015 Feb; 6(4):2120-33. PubMed ID: 25544767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse embryonic stem cells with aberrant transforming growth factor beta signalling exhibit impaired differentiation in vitro and in vivo.
    Goumans MJ; Ward-van Oostwaard D; Wianny F; Savatier P; Zwijsen A; Mummery C
    Differentiation; 1998 Jul; 63(3):101-13. PubMed ID: 9697304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
    Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro.
    Brown KA; Aakre ME; Gorska AE; Price JO; Eltom SE; Pietenpol JA; Moses HL
    Breast Cancer Res; 2004; 6(3):R215-31. PubMed ID: 15084245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma.
    Cardillo MR; Lazzereschi D; Gandini O; Di Silverio F; Colletta G
    Anal Quant Cytol Histol; 2001 Apr; 23(2):109-17. PubMed ID: 11332076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo.
    Quan T; He T; Kang S; Voorhees JJ; Fisher GJ
    J Invest Dermatol; 2002 Aug; 119(2):499-506. PubMed ID: 12190876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition.
    Wang XJ; Greenhalgh DA; Bickenbach JR; Jiang A; Bundman DS; Krieg T; Derynck R; Roop DR
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2386-91. PubMed ID: 9122204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition.
    Lacher MD; Tiirikainen MI; Saunier EF; Christian C; Anders M; Oft M; Balmain A; Akhurst RJ; Korn WM
    Cancer Res; 2006 Feb; 66(3):1648-57. PubMed ID: 16452224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis.
    Ito Y; Sarkar P; Mi Q; Wu N; Bringas P; Liu Y; Reddy S; Maxson R; Deng C; Chai Y
    Dev Biol; 2001 Aug; 236(1):181-94. PubMed ID: 11456453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High tumor grade in salivary gland mucoepidermoid carcinomas and loss of expression of transforming growth factor beta receptor type II.
    Dillard DG; Muller S; Cohen C; Bloch D; Del Gaudio JM; Gal AA
    Arch Otolaryngol Head Neck Surg; 2001 Jun; 127(6):683-6. PubMed ID: 11405868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly.
    Tian YC; Phillips AO
    Am J Pathol; 2002 May; 160(5):1619-28. PubMed ID: 12000714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.